Jobs / United States / Novartis Pharmaceuticals Corporation
Access Strategy Lead - Oncology
Novartis Pharmaceuticals Corporation · 🇺🇸 Santo Amaro
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles3 certified filings for “ED, Portfolio & Early Pipeline Strategy” (Marketing Managers) in NJ: $199k–$199k, median $199k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 3 days agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary #LI-Hybrid Location: São Paulo/SP Lead the development and execution of the Oncology access strategy across the product lifecycle, translating patient needs, business priorities and payer dynamics into integrated access plans that enable timely and sustainable access to innovative Oncology treatments. The role is accountable for shaping the access ambition, value proposition, pricing and reimbursement approach, stakeholder strategy and launch readiness for assigned Oncology assets. Acting as the senior access partner for the Therapeutic Area, the position influences critical cross-functional and portfolio decisions, aligns local priorities with regional and global direction, and supports the Access Strategy Head in maximizing patient access and the long-term value of the Oncology portfolio. This role is based in São Paulo, Brazil. Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you. Job Description Key responsibilities • Own the end-to-end access strategy for assigned Oncology assets from early development and pre-launch through launch, growth and lifecycle management, defining the access ambition, indication sequencing and strategic priorities based on patient needs, market context, payer dynamics and business objectives . • Translate product strategy into clear public and private access pathways covering reimbursement, affordability, pricing and contracting, while providing Value & Access input into target product profiles and key asset, indication and launch decisions. • Act as the senior Access Strategy partner for Oncology brand and asset teams, embedding access considerations into medical, commercial, regulatory and launch plans and leading cross-functional delivery against clear outcomes, milestones, dependencies, risks and ownership. • Develop payer segmentation, engagement objectives , value narratives and strategic messages, build trusted relationships with relevant healthcare decision makers, and represent the organization in negotiations and access policy discussions within approved mandates and governance. • Identify payer evidence requirements and strategic evidence gaps, translating them into business needs and partnering with Medical, HEOR and other expert teams on evidence-generation planning and execution. • Lead the access component of Oncology launch readiness, including the critical path for pricing, reimbursement, funding, channels and stakeholder preparation, while assessing healthcare-system readiness, patient-journey barriers and local implementation needs. • Anticipate access risks and market changes, develop scenarios and mitigation actions, and provide concise recommendations to decision-making forums while ensuring local input and high-quality deliverables for regional and global launch planning. • Lead lifecycle and portfolio value planning across new indications, label extensions, reimbursement expansion, contract renewals and value-proposition refinement, monitoring performance and recommending corrective or acceleration actions. • Co-lead strategic assessments for pricing and contracting recommendations with Pricing, evaluate portfolio interdependencies, and advise on the prioritization of access initiatives, investments and resources across assigned Oncology assets. • Prepare executive-ready recommendations and decision materials, ensure compliance with legal, ethical and governance requirements, and promote continuous improvement, knowledge sharing and leadership through influence across the access community. Essential Requirements • Bachelor’s degree in Pharmacy, Life Sciences, Economics, Business Administration, Public Health or a related field; fluent Portuguese an